The elevated expression of PD-L1 in cancer cells was recognized as a consequence of tumor immune escape and a biomarker for the prediction of immune checkpoint inhibitors (Chemnitz et al., 2004; Jiang et al., 2019). Here, CD274 is linked to neoplasm.